Life Molecular Imaging (LMI), an international pharmaceutical company dedicated to developing and offering novel cutting-edge PET radiopharmaceuticals for imaging, and SOFIE Biosciences (SOFIE), a ...

Nearly half of high-risk prostate cancer patients classified as nonmetastatic by traditional imaging show metastases when ...

Advanced imaging reveals hidden metastases in high-risk prostate cancer cases, offering new insights for better diagnosis and treatment strategies.

SYDNEY, AUSTRALIA and LITTLE ROCK, AR / ACCESSWIRE / January 3, 2025 / GlyTherix Ltd (GlyTherix), an Australian targeted radiotherapy company, and 3D Imaging LLC (3DI), a Contract Development and Manu ...

GlyTherix Ltd (GlyTherix), an Australian targeted radiotherapy company, and 3D Imaging LLC (3DI), a Contract Development and Manufacturing Organization (CDMO) specializing in radiopharmaceuticals, are ...

New software enables INL to rapidly inspect 3D-printed nuclear parts, enhancing safety and material evaluation efficiency.

Scanning radioactive nuclear fuels and materials is the specialty of INL's Irradiated Materials Characterization Lab, where ...

Scanning radioactive nuclear fuels and materials is the specialty of INL’s Irradiated Materials Characterization Lab, where Chuirazzi works. An array of shielding and other precautions is required to ...

Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) and the Brussels-based Oncidium foundation today ...